TVRD – tvardi therapeutics, inc. (US:NASDAQ)
Stock Stats
News
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
Form 8-K Tvardi Therapeutics, For: Nov 19
Form SCHEDULE 13G/A Tvardi Therapeutics, Filed by: DePinho Ronald A
Form S-8 Tvardi Therapeutics,
Form S-1/A Tvardi Therapeutics,
Form 8-K Tvardi Therapeutics, For: Oct 13
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.